¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Disorder of lacrimal system, unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • ion channel disorder
    ÀÌ¿ÂÅë·ÎÁúȯ
  • immune disorder
    ¸é¿ªÁúȯ, ¸é¿ªÀå¾Ö
  • immunoproliferative disorder
    ¸é¿ªÁõ½ÄÀå¾Ö
  • impulse control disorder
    Ãæµ¿Á¶ÀýÀå¾Ö
  • identity disorder
    Á¤Ã¼¼ºÀå¾Ö
  • intermittent explosive disorder
    °£ÇæÆø¹ßÀå¾Ö
  • intestinal motility disorder
    âÀڿÀå¾Ö, Àå¿îµ¿Àå¾Ö
  • language disorder
    ¾ð¾îÀå¾Ö
  • learning disorder
    ÇнÀÀå¾Ö
  • lymphoproliferative disorder
    ¸²ÇÁ¼¼Æ÷Áõ½ÄÁúȯ
  • micturition disorder
    ¹è´¢Àå¾Ö
  • malabsorptive disorder
    Èí¼öÀå¾ÖÁúȯ
  • minor depressive disorder
    °æµµ¿ì¿ïÀå¾Ö
  • mitochondrial disorder
    »ç¸³Ã¼Áúȯ, ¹ÌÅäÄܵ帮¾ÆÁúȯ
  • mood disorder
    ±âºÐÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • cyclothymic disorder
    ¼øÈ¯¼º±âºÐÀå¾Ö
  • disorder
    Àå¾Ö, Áúȯ
  • delusional disorder
    ¸Á»óÀå¾Ö
  • demyelinating disorder
    ¸»ÀÌÁýÅ»¶ôÁúȯ
  • dependent personality disorder
    ÀÇÁ¸ÀΰÝÀå¾Ö
  • depersonalization disorder
    ÀÌÀÎÀå¾Ö
  • depressive disorder
    ¿ì¿ïÀå¾Ö
  • developmental disorder
    ¹ß´ÞÀå¾Ö
  • developmental receptive language disorder
    ¹ß´Þ¼ö¿ë¾ð¾îÀå¾Ö
  • dissociative disorder
    ÇØ¸®Àå¾Ö, ÇØ¸®º´
  • dysthymic disorder
    ±âºÐÀúÇϺ´, ±âºÐÀúÇÏÀå¾Ö
  • eating disorder
    ¸Ô±âÀå¾Ö, ¸Ô±âº´
  • electrolyte disorder
    ÀüÇØÁúÀå¾Ö
  • extrapyramidal disorder
    Ãßü¿Ü·ÎÀå¾Ö
  • factitious disorder
    ÀÎÀ§ÀûÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • genital system
    »ý½Ä°èÅë
  • genital system
    »ý½Ä±â°è(ßæãÖÐïͧ)
  • genitourinary system
    ºñ´¢»ý½Ä±â°èÅë(ù²èñßæãÖÐïͧ÷Ö).
  • genitourinary system
    ºñ´¢»ý½Ä±â°èÅë(ù²èñßæãÖÐïͧ÷Ö).
  • glial cell of central nervous system
    ÁßÃ߾Ʊ³¼¼Æ÷
  • glial cell of peripheral nervous system
    ¸»ÃʾƱ³¼¼Æ÷
  • global budget system
    ÃѾ׿¹»êÁ¦, ÃѾװè¾àÁ¦.
  • guarantee system
    º¸ÁõÁ¦µµ(ËÓ̡̡̬).
  • h2o2-myeloperxidase-halide system
    °ú»êÈ­¼ö¼Ò-°ñ¼ö°ú»êÈ­È¿¼Ò-ÇÒ·Î°Õ °èÅë
  • hamatopoietic system
    Á¶Ç÷±â°ü(ðãúìÐïί)
  • health care delivery system
    ÀÇ·áÀü´ÞÁ¦µµ(ËöËíËøËÀ̡̬).
  • health care system
    º¸°ÇÀÇ·áü°è.
  • health information system
    º¸°ÇÁ¤º¸Ã¼°è.
  • heterogeneous system
    ºÒ±ÕÀϰè, ºÒ±ÕÁú°è.
  • hexagonal system
    À°¹æ°áÁ¤°è.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • brief psychotic disorder
    ´Ü±âÁ¤½Åº´Àû Àå¾Ö
  • caffeine - related disorder
    Ä«ÆäÀÎ °ü·ÃÀå¾Ö(º´)
  • calcium disorder
    Ä®½·Áúȯ
  • cannabis - related disorder
    ´ë¸¶°ü·ÃÀå¾Ö(º´)
  • cell migration disorder
  • central auditroy procelling disorder
  • childhood disintegrative disorder
    ¼Ò¾Æ±â ºØ±«¼º Àå¾Ö
  • chronic factitious disorder with physical symptoms
    ¸¸¼º ÀΰøÀû Àå¾Ö ½ÅüÀû
  • chronic motor or vocal tic disorder
    ¸¸¼º ¿îµ¿¼º ȤÀº À½¼ºÆ½ Àå¾Ö
  • chronic myeloproliferative disorder
    ¸¸¼º °ñ¼öÁõ½Ä¼º Áúȯ
  • circadian rhythm sleep disorder
    ÀÏÁÖ±â À²µ¿ ¼ö¸éÀå¾Ö(ìíñÎÑ¢ ëÏÔÑ â²Øùî¡äô)
  • coagulation disorder
    ÀÀ°íÀÌ»ó(¡­ì¶ßÈ), ÀÀ°íÀå¾Ö(¡­î¡äô).
  • coagulation disorder
    ÀÀ°íÀÌ»ó
  • cognitive disorder
    ÀÎÁöÀå¾Ö(ìãò±î¡äô)
  • communication disorder
    ÀÇ»ç¼ÒÅë Àå¾Ö(ëòÞÖáÂ÷×î¡äô)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
GBD gallbladder disease; gender behavior disorder; glass blower's disease; granulomatous bowel disease
GID gender identity disorder
GMCD grand mal convulsive disorder
HID headache, insomnia, depression [syndrome]; herniated intervertebral disc; human infectious dose; hyp...
IAHD idiopathic acquired hemolytic disorder
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
SD Somatization disorder
TDI Thought Disorder Index
TD Tourette Disorder
TMD Transient myeloproliferative disorder
AD anxiety disorder
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • control system
    Á¶Àý°è
  • corticospinal system
    ÇÇÁú ô¼ö°è
  • countercurrent system
    ¿ª·ù°è, ´ëÇâ·ù°è
  • crystal system
    Á¤°è, °áÁ¤°è
  • cyclic AMP system
    ȯ»ó AMP °è
  • descending inhibitory system
    ÇÏÇà ¾ïÁ¦°è
  • digestive system
    ¼ÒÈ­±â °èÅë
  • disease of the lymphreticular system
    ¸²ÇÁ ¼¼¸Á³»ÇǰèÀÇ Áúȯ
  • DNA repair system
    DNA º¸¼ö ±â±¸
  • dopaminergic system
    µµÆÄ¹Î ü°è
  • drug delivery system
    ¾à¹° Åõ¿©±â, ¾à¹° Åõ¿© üÁ¦, ¾à¹° Àü´Þ ü°è
  • dual foil system
    ÀÌÁß ¹Ú¸· ±¸Á¶
  • ductal system
    µµ°ü°è
  • dynamic system
    µ¿Àû °èÅë
  • ectopic system
    »ýŰè
    ¾î¶² Áö¿ªÀÇ »ý¹° °øµ¿Ã¼¿Í À̰ÍÀ» À¯ÁöÇϰí ÀÖ´Â ¹«±âÀû ȯ°æÀÌ Á¾ÇÕµÈ ¹°Áú°è ¶Ç´Â ±â´É°è. »ýŰè¶õ ¿µ±¹ÀÇ A.G. ÅĽ½¸®¿¡ ÀÇÇÏ¿© 1935³â Á¦Ã¢µÈ ¿ë¾î·Î, ÀÚ¿¬ÀÇ ÀÖ´Â ±×´ë·ÎÀÇ »óŸ¦ ÀνÄÇϱâ À§Çؼ­´Â ÀÌ°Íµé »óÈ£°£ÀÇ °ü°è¸¦ Áö´Ñ »ý¹°°ú ¹«±âÀû ȯ°æÀ» Çϳª·Î ÅëÇÕÇØ¾ß ÇÑ´Ù´Â °ÍÀÌ ÅĽ½¸®°¡ Á¦Ã¢ÇÑ °³³äÀÌ´Ù. Áö±¸ »ýŰè´Â ±× ³ÐÀÌ¿¡¼­´Â »ý¹°±Ç°ú ÀÏÄ¡ÇÑ´Ù. ¹«±âÀû ȯ°æÀÇ Æ¯Â¡¿¡ ÀǰÅÇÏ¿© ÇØ¾ç »ýŰè, È£¼Ò »ýŰè, ±ØÁö »ýŰè, »ç¸· »ýÅÂ°è µîÀ¸·Î ±¸º°Çϰí, ¶Ç ±º¶ôÀÇ »ó°ü¿¡ µû¶ó¼­ »ï¸² »ýŰè, ÃÊÁö »ýÅÂ°è µîÀ¸·Î ±¸ºÐÇϱ⵵ ÇÑ´Ù. ¶ÇÇÑ, °æÁö »ýŰè, µµ½Ã »ýŰè¿Í °°Àº °Íµµ »ý°¢ÇÒ ¼ö ÀÖ´Ù. »ýŰè Áß¿¡¼­ »ý¹°Ã¼´Â ±â´ÉÀûÀ¸·Î »ý»êÀÚ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
renal portal system An arterial portal system, in which efferent glomerular arterioles receive blood from the capillaries of the renal glomeruli and carry it to the peritubular capillary plexus surrounding the proximal and distal convoluted tubules.
Synonym: hypothalamohypophysial portal system.
(05 Mar 2000)
p blood-group system A blood group related to the abo, lewis and I systems. at least five different erythrocyte antigens are possible, some very rare, others almost universal. Multiple alleles are involved in this blood group.
(12 Dec 1998)
renin-angiotensin-aldosterone system The hormones, renin, angiotensin, and aldosterone work together to regulate blood pressure. A sustained fall in blood pressure causes the kidney to release renin. This is converted to angiotensin in the circulation. Angiotensin then raises blood pressure directly by arteriolar constriction and stimulates adrenal gland to produce aldosterone which promotes sodium and water retention by kidney, such that blood volume and blood pressure increase.
(05 Mar 2000)
renin-angiotensin system <physiology> A system consisting of renin, angiotensin-converting enzyme, and angiotensin II.
Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming angiotensin I. The converting enzyme contained in the lung acts on angiotensin I in the plasma converting it to angiotensin II, the most powerful directly pressor substance known. It causes contraction of the arteriolar smooth muscle and has other indirect actions mediated through the adrenal cortex.
(25 Jun 1999)
centimeter-gram-second system The scientific system of expressing the fundamental physical units of length, mass, and time, and those units derived from them, in centimeters, grams, and seconds; currently being replaced by the International System of Units based on the meter, kilogram, and second.
(05 Mar 2000)
reproductive system In women, the organs that are directly involved in producing eggs and in conceiving and carrying babies.
(12 Dec 1998)
pedal system Efferent fibres connecting the forebrain with more caudal structures.
(05 Mar 2000)
central nervous system <anatomy, neurology> Pertaining to the brain, cranial nerves and spinal cord. It does not include muscles or peripheral nerves.
In invertebrates, the central nervous system is composed of the segmental ganglia of the ventral nerve cord together with the fused ganglia or brain at the anterior end.
Acronym: CNS
(12 Jan 1998)
central nervous system agents A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "non-specific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with non-specific mechanisms are generally further classed according to whether they produce behavioural depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use.
(12 Dec 1998)
central nervous system depressants A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anaesthetics, hypnotics and sedatives, narcotics, and tranquillising agents (antipsychotics and antianxiety agents).
(12 Dec 1998)
central nervous system infections Diseases of the central nervous sytem collectively, caused by pathogenic organisms.
(12 Dec 1998)
central nervous system neoplasms Neoplasms located in the brain, spinal cord, or meninges.
(12 Dec 1998)
central nervous system stimulants A loosely defined group of drugs that tend to increase behavioural alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
(12 Dec 1998)
glycogen debranching enzyme system 1,4-alpha-d-glucan-1,4-alpha-d-glucan 4-alpha-d-glucosyltransferase/dextrin 6 alpha-d-glucanohydrolase. An enzyme system having both 4-alpha-glucanotransferase (ec 2.4.1.25) and amylo-1,6-glucosidase (ec 3.2.1.33) activities. As a transferase it transfers a segment of a 1,4-alpha-d-glucan to a new 4-position in an acceptor, which may be glucose or another 1,4-alpha-d-glucan. As a glucosidase it catalyses the endohydrolysis of 1,6-alpha-d-glucoside linkages at points of branching in chains of 1,4-linked alpha-d-glucose residues. Amylo-1,6-glucosidase activity is deficient in glycogen storage disease type III.
(12 Dec 1998)
respiratory system The organs that are involved in breathing. These include the nose, throat, larynx, trachea, bronchi, and lungs.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
ÅëÇÕ°Ë»ö ¿Ï·á